BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
S.H. Lim, W. Chua, C. Henderson, W. Ng, J.-S. Shin, L. Chantrill, R. Asghari, C.S. Lee, K.J. Spring, P. de Souza. Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancerCritical Reviews in Oncology/Hematology 2015; 96(1): 67 doi: 10.1016/j.critrevonc.2015.05.003
Prachi M Patel, Kelly Harris, Sergio Huerta. Clinical and molecular diagnosis of pathologic complete response in rectal cancerExpert Review of Molecular Diagnostics 2015; 15(11): 1505 doi: 10.1586/14737159.2015.1091728
Bernard Tawfik, Ali A. Mokdad, Prachi M. Patel, Hsiao C. Li, Sergio Huerta. The neutrophil to albumin ratio as a predictor of pathological complete response in rectal cancer patients following neoadjuvant chemoradiationAnti-Cancer Drugs 2016; 27(9): 879 doi: 10.1097/CAD.0000000000000411
Corey Timmerman, Luis R. Taveras, Sergio Huerta. Clinical and molecular diagnosis of pathologic complete response in rectal cancer: an updateExpert Review of Molecular Diagnostics 2018; 18(10): 887 doi: 10.1080/14737159.2018.1514258
Jonathan Imran, Sergio Huerta. Nitric Oxide as a Chemosensitizing Agent2017; : 155 doi: 10.1016/B978-0-12-811020-1.00009-0
Divya B. Bhatt, Valerie-Sue Emuakhagbon. Current Trends in Colorectal Cancer ScreeningCurrent Colorectal Cancer Reports 2019; 15(2): 45 doi: 10.1007/s11888-019-00432-4
Felix Harpain, Mohamed A. Ahmed, Xenia Hudec, Gerald Timelthaler, Gerd Jomrich, Leonhard Müllauer, Edgar Selzer, Wolfgang Dörr, Michael Bergmann, Klaus Holzmann, Bettina Grasl-Kraupp, Michael Grusch, Walter Berger, Brigitte Marian, Gerd R. Silberhumer. FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancerJournal of Cancer Research and Clinical Oncology 2019; 145(1): 77 doi: 10.1007/s00432-018-2757-7